Glecaprevir/pibrentasvir
WORLD JOURNAL OF HEPATOLOGY(2023)
摘要
Glecaprevir/pibrentasvir in combination with sofosbuvir may serve as a safe and effective option for treatment of recurrent hepatitis C virus post-liver transplant in patients who previously failed direct-acting antivirals.
更多查看译文
关键词
Hepatitis C virus,Direct-acting antivirals,Liver transplantation,Glecaprevir,pibrentasvir,Sofosbuvir,Ribavirin
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要